1 |
Kuchay MS, Mithal A. Levosulpiride and Serum Prolactin Levels. Indian J End Metab 2017;21:355-8.
DOI
|
2 |
Ministry of Food and Drug Safety (MFDS). Levosulpiride Label. Available from http://drug.mfds.go.kr/html/bxsSearchDrugProduct.jsp?item_Seq=200000519. Accessed December 10, 2017.
|
3 |
Food and Drug Administration (FDA). FDA Approved Drug Products. Available from https://www.accessdata.fda.gov/scripts/cder/daf/. Accessed December 10, 2017.
|
4 |
European Medicines Agency (EMA) Medicine Label. Available from http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/medicines/medicines_landing_page.jsp&mid=. Accessed December 10, 2017.
|
5 |
Hankyoreh. The mean number of prescribing medicines is four which is doulble of the U.S.; caused by unrestricted prescribing for antipeptic agents. Available from http://www.hani.co.kr/arti/society/health/246809.html. Accessed February 10, 2018.
|
6 |
Korean Pharmaceutical Association. Press Releases. Available from http://kpanet.or.kr/. Accessed April 10, 2018.
|
7 |
Rehan HS, Chopra D, Kakkar AK. Causality assessment of spontaneously reported adverse drug events: Comparison of WHO-UMC criteria and Naranjo probability scale. Int J Risk Saf Med 2007;19(4):223-7.
|
8 |
Belhekar MN., Taur SR, Munshi RP. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions. Indian J Pharmacol 2017;46:117-20.
|
9 |
Kyung EJ, Ryu JH, Kim EY. Evaluation of adverse reactions to contrast media in the hospital. Briti J Radiol 2013;86:20130418.
|
10 |
Korea Institute of Drug Safety & Risk Mangement. Korean Pharmaceutical Association. News Letter for Regional Pharmacovigillance Center 2017.
|
11 |
Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci 2013;6:168-75.
DOI
|